The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis
Written by suman butlerTargeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities ..